International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines

Food and Healthcare Press Releases Thursday August 29, 2019 08:00
ADDIS ABABA, Ethiopia and PLYMOUTH MEETING, Pennsylvania--29 Aug--PRNewswire/InfoQuest

National Comprehensive Cancer Network, African Cancer Coalition, and American Cancer Society launch new phase focused on updating adult cancer guidelines and adding new guidelines for treating children with cancer.

NCCN Harmonized Guidelines(TM) for Sub-Saharan Africa endorsed in six countries representing nearly half the region's population.

A collaborative project from the National Comprehensive Cancer Network(R) (NCCN(R)), the African Cancer Coalition (ACC), the American Cancer Society (ACS), and others to improve cancer outcomes in Sub-Saharan Africa enters a new phase in Addis Ababa, Ethiopia, today. Oncologists from 11 African countries—along with the CEOs of ACS and NCCN—are attending a meeting hosted by the Ethiopian Health Minister. Attendees will help finalize additional NCCN Harmonized Guidelines(TM) for Sub-Saharan Africa, bringing the total to 42 guidelines providing best practice cancer treatment recommendations for more than 86% of all adult cancer incidence in the region according to ACS.

"Cancer can be twice as lethal in Sub-Saharan Africa as it is in the United States," said Robert W. Carlson, MD, CEO, NCCN. "By providing free online access to the latest research and analysis, we can help local medical providers save more lives. More than 7,000 copies of the NCCN Harmonized Guidelines for Sub-Saharan Africa have been downloaded from the NCCN website, and many more via our mobile app."

"The American Cancer Society is proud to be part of this critical step toward standardizing cancer care in Africa," said Gary Reedy, CEO, American Cancer Society. "The harmonization of 42 NCCN Guidelines is a tremendous accomplishment that would not have been possible without the collaboration of individuals and institutions committed to advancing cancer care in Africa."

The first NCCN Harmonized Guidelines(TM) for Sub-Saharan Africa debuted in November 2017, during the biennial African Organisation for Research and Training in Cancer (AORTIC) conference in Kigali, Rwanda. In addition to covering various cancer types, they also provide treatment recommendations for pain management, survivorship, smoking cessation, and other aspects of supportive care. The full list of current and upcoming guidelines can be found at NCCN.org/harmonized.

The medical recommendations have been officially endorsed in Ethiopia, Malawi, Nigeria, Tanzania, Uganda, and Zambia. Together, those countries are home to 43% of the population of Sub-Saharan Africa.

"As African governments and specialists mount a response to the growing cancer epidemic, they identified the need for cancer treatment guidelines that reflect the most up-to-date clinical knowledge and provide flexibility for use across resource levels, from state-of-the-art cancer centers to basic community hospitals," said Prof. Isaac F. Adewole, FAS, FRCOG, FSPSP, DSc, Immediate past Honorable Minister for Health, Nigeria. "Without these guidelines, it would not be possible to scale-up access to treatment to meet the needs of people with cancer."

NCCN Harmonized Guidelines(TM) use color-coding to represent both the optimal care that low- and mid-resource countries aspire to provide and pragmatic approaches that provide effective treatment options for resource-constrained settings. They are based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R)), containing recommendations from interdisciplinary panels of experts from across the 28 leading academic cancer centers that comprise NCCN. NCCN Guidelines(R) are the recognized standard for clinical policy in cancer care and are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. They cover most types of cancer, plus supportive care, prevention, and genetic screening. NCCN began including recommendations for pediatric cancers in May 2019.

Learn more at NCCN.org/global, and join the conversation online with the hashtag #NCCNGlobal.
Media Contact:
Rachel Darwin
+1-267-622-6624
darwin@nccn.org
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

Latest Press Release

Menarini: Elcin Barker Ergun Group CEO

"Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric Cornut, Chairman of Menarini. Elcin Barker Ergun: "Menarini is a company admired on a global...

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3...

Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations

- Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications are present in 3-5% of non-small cell lung cancer patients and correlate with...

Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019

- Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study - Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal...

Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For #Complete Clearance# of Symptoms and Consider Combination Therapy For Severe Patients

Experts also welcome upsurge in the adoption of a rosacea signs and symptoms ('phenotype') led approach in clinical practice and announce the launch of prototype clinical tools to support physicians to optimize rosacea management Published online in the...

Related Topics